Learn Before
Diabetes Medication on COVID-19 Mortality
Diabetes medications appear to have differential associations with COVID-19 mortality in patients with type 2 diabetes. In a case series from Lombardy, Italy, insulin and β-blocker use were associated with higher mortality rates, while elevated plasma glucose and IL-6 levels at admission were independently associated with higher mortality, though type 2 diabetes itself was not independently associated with mortality risk after adjusting for age and sex.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
COVID-19 and diabetes: Knowledge in progress
The Link Between Diabetes and ACE2
Diabetes in COVID-19 Patients by Geographic Location
Diabetes Mellitus and a study of its Epidemiology in relation to COVID-19
The effect of hyperglycemia in relation ot COVID-19
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
How Elevated Glucose Levels Favor SARS-CoV-2 Infection?
Diabetes Medication on COVID-19 Mortality
Effect of Degree of Hyperglycemia on COVID-19 Mortality